Pirro V, Roth KD, Lin Y, Willency JA, Milligan PL, Wilson JM, Ruotolo G, Haupt A, Newgard CB, Duffin KL
BPC-157 Mechanism of Action in Research Models BPC-157 is investigated for interactions with nitric-oxide signalling, angiogenesis-related markers, fibroblast activity, extracellular matrix remodelling and inflammatory mediator balance
Based on animal study timelines, vascular and cellular effects may begin within the first week of treatment
Monitoring may include hormone panels, IGF-1, fasting glucose, A1c, inflammatory markers, symptom tracking, and assessment of recovery progress
They are not intended for human or animal use , including but not limited to consumption, injection, inhalation, topical application, diagnosis, treatment, cure, or prevention of any disease or medical condition